China has set strict IPO criteria for humanoid robot firms, signaling a cooling market for AI stocks.
BEIJING — The China Securities Regulatory Commission (CSRC) is tightening its grip on the public listings of humanoid robot startups, introducing three new specific criteria that these companies must meet to pursue initial public offerings (IPOs). This change reflects an evolving market landscape, as investors worldwide reconsider the inflation of artificial intelligence stock prices.
Sources familiar with the CSRC's decision reported that the regulator is scrutinizing the more than 100 local startups involved in embodied AI, a term that encompasses humanoid robotics. The implementation of these criteria comes at a time when the sector, which has garnered exponential interest and investment, appears to be cooling.
The new standards set by the CSRC mark a more challenging environment for robot startups seeking market entry. Although one source indicated that a company may only need to meet two out of the three criteria, it is still uncertain how many startups can satisfy even these minimal requirements. Consequently, the overall expectations are now significantly lowered, with very few, if any, companies poised to enter public markets in the near future.
As of recent reports, at least two dozen technology-driven humanoid-related companies have already filed for IPOs in Hong Kong. This follows the Hong Kong stock exchange's decision in May 2025 to allow startups to file for IPOs confidentially. However, the CSRC's approval remains crucial for companies based in mainland China to list on the Hong Kong exchange.
The CSRC's heightened scrutiny comes in light of the rapid acceleration in valuations observed in China's humanoid robotics sector, fueled by a blend of government support and private capital investments. Most notably, one of the industry's frontrunners, Unitree, recently made headlines for its IPO in Shanghai on August 19. Their shares surged over 460% on debut, generating about 6.1 billion yuan ($905 million). However, a sharp decline followed; the stock price fell to 459.65 yuan by the beginning of the following week, which marked a nearly 50% decrease from its peak.
The humanoid robot industry faces significant challenges beyond initial listings. During a keynote speech at the World Robot Conference in Beijing, Unitree's founder, Wang Xingxing, emphasized the obstacles related to commercializing humanoid robots beyond basic functions, like dancing. He mentioned that this longer-term vision remains several years from realization.
This candor highlights a crucial debate amongst stakeholders: what practical applications can humanoid robots provide, and can startups sustain profitability? Recent market trends suggest optimism is tempered by a need for tangible revenue generation.
Investment in the sector appears overwhelmingly optimistic on the surface, with capital inflows reaching approximately 47.09 billion yuan ($6.95 billion) in the second quarter, more than doubling that of the first quarter. This surge denotes a remarkable sixfold increase compared to the same quarter last year, reflecting heightened investor interest.
The juxtaposition between soaring funding and plummeting stock performance is stark. Ubtech, a Hong Kong-listed humanoid robotics company that went public in December 2023, experienced a decline exceeding 40% in 2026, despite a reported operating loss of 279 million yuan for the first half of the year.
Such a performance raises questions about the sustainability of valuations. According to an analysis from Rhodium Group, while AI companies in the U.S., such as Anthropic and OpenAI, generate considerable returns, China's counterparts are significantly lagging. Chinese AI companies currently garner approximately 10% of the revenue compared to their U.S. peers, raising concerns about overvaluation in the context of capital market expectations.
Looking ahead, expectations for IPOs among U.S. AI powerhouses remain high, especially as companies like AMD prepare significant acquisitions — such as its $8.2 billion stock deal for World Labs, aimed at developing advanced AI technologies. These developments contrast sharply with the trajectory of Chinese humanoid startups.
China's humanoid robotics sector is at a crossroads. Enhanced regulatory scrutiny, coupled with inconsistent financial performance, raises pertinent questions about the overall viability of the industry. As the CSRC continues to enforce its stricter IPO criteria, only time will tell how the market will react and what new stages of innovation and investment will emerge from this volatility.